Immuno Cure, it is a biotechnology company it is specialized in the study and creation of immunotherapies.
Immuno Cure has raised $8.5M in total funding. The most recent round was Grant. The last funding was announced in July 2024.
Immuno Cure's investors include Hong Kong Science and Technology Parks Corporation, Gobi Partners GBA, University Grants Committee.
Immuno Cure is headquartered in Sha Tin, Hong Kong.
Immuno Cure, it is a biotechnology company it is specialized in the study and creation of immunotherapies.
Immuno Cure is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Immuno Cure — Funding & Investors." VCBacked, July 18, 2024, https://www.vcbacked.co/company/immuno-cure. Accessed July 30, 2026.
VCBacked. (2024). Immuno Cure — Funding & Investors. Retrieved July 30, 2026, from https://www.vcbacked.co/company/immuno-cure
{{cite web |title=Immuno Cure — Funding & Investors |url=https://www.vcbacked.co/company/immuno-cure |website=VCBacked |access-date=July 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated